Multistep skin cancer in mice as a model to study the evolution of cancer cells

Seminars in Cancer Biology

Volumn 15, Issue 6, 2005, Pages 460-473

  Kemp, Christopher J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Buffering; Neoplastic progression; p53; Ras; Skin cancer

Indexed keywords

CARCINOGEN; PROTEIN P53; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER STAGING; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; DNA MODIFICATION; DNA REPAIR; EPIGENETICS; GENE MUTATION; HAPLOTYPE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; PHENOTYPE; REVIEW; SKIN CANCER; SKIN TUMOR; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EVOLUTION, MOLECULAR; GENES, RAS; MICE; MODELS, GENETIC; MUTATION; PHENOTYPE; SKIN NEOPLASMS;

EID: 24944535307     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.06.003     Document Type: Review

References (115)

1. P.C. Nowell The clonal evolution of tumor cell populations Science 194 4260 1976 23 28
2. M.J. Renan How many mutations are required for tumorigenesis? Implications from human cancer data Mol Carcinog 7 1993 139 146
3. L.A. Loeb Mutator phenotype may be required for multistage carcinogenesis Cancer Res 51 1991 3075 3079
4. I.P. Tomlinson, M.R. Novelli, and W.F. Bodmer The mutation rate and cancer Proc Natl Acad Sci USA 93 25 1996 14800 14803
5. S.H. Moolgavkar, and E.G. Luebeck Multistage carcinogenesis and the incidence of human cancer Genes Chromosomes Cancer 38 4 2003 302 306
6. P.A. Jones, and P.W. Laird Cancer epigenetics comes of age Nat Genet 21 2 1999 163 167
7. G.L. Nicolson Cell surface molecules and tumor metastasis Regulation of metastatic phenotypic diversity Exp Cell Res 150 1 1984 3 22
8. M. Oft, J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells Genes Dev 10 19 1996 2462 2477
9. W. Cui, D.J. Fowlis, S. Bryson, E. Duffie, H. Ireland, and A. Balmain TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice Cell 86 4 1996 531 542
10. J. Philipp, K. Vo, K.E. Gurley, K. Seidel, and C.J. Kemp Tumor suppression by p27/Kip1 and p21/Cip1 during chemically induced skin carcinogenesis Oncogene 18 1999 4689 4698
11. A.G. Knudson Genetics of human cancer Annu Rev Genet 20 1986 231 251
12. M.L. Fero, E. Randel, K.E. Gurley, J.M. Roberts, and C.J. Kemp The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature 396 1998 177 180
13. Payne SR, Kemp CJ. Tumor suppressor genetics. Carcinogenesis, in press.
14. J. Philipp-Staheli, S.R. Payne, and C.J. Kemp p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer Exp Cell Res 264 1 2001 148 168
15. S.H. Yuspa The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - 33rd G.W.A. Clowes Memorial Award Lecture Cancer Res 54 1994 1178 1189
16. A. Balmain, and C.C. Harris Carcinogenesis in mouse and human cells: parallels and paradoxes Carcinogenesis 21 3 2000 371 377
17. R.K. Boutwell, A.K. Verma, C.L. Ashendel, and E. Astrup Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis Carcinog Comp Surv 7 1982 1 12
18. M. Quintanilla, K. Brown, M. Ramsden, and A. Balmain Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis Nature 322 1986 78 80
19. R. Bremner, and A. Balmain Genetic changes in skin tumour progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 Cell 61 1990 407 417
20. P.A. Burns, C.J. Kemp, J.V. Gannon, D.P. Lane, R. Bremner, and A. Balmain Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice Oncogene 6 1991 2363 2369
21. B. Ruggeri, J. Caamano, T. Goodrow, M. DiRado, A. Bianchi, and D. Trono Alterations of the p53 tumor suppressor gene during mouse skin tumor progression Cancer Res 51 1991 6615 6621
22. B. Bailleul, M.A. Surani, S. White, S.C. Barton, K. Brown, and M. Blessing Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter Cell 62 1990 697 708
23. K. Brown, M. Quintanilla, M. Ramsden, I.B. Kerr, S. Young, and A. Balmain v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis Cell 46 1986 447 456
24. K. Brown, A. Buchmann, and A. Balmain Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumour progression Proc Natl Acad Sci USA 87 1990 538 542
25. K. Ise, K. Nakamura, K. Nakao, S. Shimizu, H. Harada, and T. Ichise Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis Oncogene 19 26 2000 2951 2956
26. A.L. Reddy, and P.J. Fialkow Papillomas induced by initiation-promotion differ from those induced by carcinogen alone Nature 304 1983 69 71
27. D.J. Winton, M.A. Blount, and B.A. Ponder Polyclonal origin of mouse skin papillomas Br J Cancer 60 1989 59 63
28. H. Nagase, J.H. Mao, and A. Balmain Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice Cancer Res 63 16 2003 4849 4853
29. M. Miyata, G. Kudo, Y.H. Lee, T.J. Yang, H.V. Gelboin, and P. Fernandez-Salguero Targeted disruption of the microsomal epoxide hydrolase gene Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene J Biol Chem 274 34 1999 23963 23968
30. C.J. Henderson, A.G. Smith, J. Ure, K. Brown, E.J. Bacon, and C.R. Wolf Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases Proc Natl Acad Sci USA 95 9 1998 5275 5280
31. A. de Vries, C.T. van Oostrom, F.M. Hofhuis, P.M. Dortant, R.J. Berg, and F.R. de Gruijl Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA Nature 377 6545 1995 169 173
32. H. Nakane, S. Takeuchi, S. Yuba, M. Saijo, Y. Nakatsu, and H. Murai High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene Nature 377 6545 1995 165 168
33. J. de Boer, H. van Steeg, R.J. Berg, J. Garssen, J. de Wit, and C.T. van Oostrum Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition Cancer Res 59 14 1999 3489 3494
34. K. Becker, J. Dosch, C.M. Gregel, B.A. Martin, and B. Kaina Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis Cancer Res 56 14 1996 3244 3249
35. C.J. Kemp, K. Vo, and K.E. Gurley Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis Carcinogenesis 20 11 1999 2051 2056
36. L. Moore, S. Venkatachalam, H. Vogel, J.C. Watt, C.L. Wu, and H. Steinman Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis Oncogene 22 49 2003 7831 7837
37. G.A. Repasky, E.J. Chenette, and C.J. Der Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol 14 11 2004 639 647
38. P. Rodriguez-Viciana, and F. McCormick RalGDS comes of age Cancer Cell 7 3 2005 205 206
39. A. Suzuki, S. Itami, M. Ohishi, K. Hamada, T. Inoue, and N. Komazawa Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation Cancer Res 63 3 2003 674 681
40. J.H. Mao, M.D. To, J. Perez-Losada, D. Wu, R. Del Rosario, and A. Balmain Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression Genes Dev 18 15 2004 1800 1805
41. A. Malliri, R.A. van der Kammen, K. Clark, V. van d, F. Michiels, and J.G. Collard Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours Nature 417 6891 2002 867 871
42. Y. Bai, H. Edamatsu, S. Maeda, H. Saito, N. Suzuki, and T. Satoh Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development Cancer Res 64 24 2004 8808 8810
43. A. Gonzalez-Garcia, C.A. Pritchard, H.F. Paterson, G. Mavria, G. Stamp, and C.J. Marshall RalGDS is required for tumor formation in a model of skin carcinogenesis Cancer Cell 7 3 2005 219 226
44. N. Chen, M. Nomura, Q.B. She, W.Y. Ma, A.M. Bode, and L. Wang Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice Cancer Res 61 10 2001 3908 3912
45. J.L. Hartman, B. Garvik, and L. Hartwell Principles for the buffering of genetic variation Science 291 5506 2001 1001 1004
46. A.M. Dominey, X.J. Wang, L.E. King Jr., L.B. Nanney, T.A. Gagne, and K. Sellheyer Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas Cell Growth Differ 4 12 1993 1071 1082
47. R. Vassar, M.E. Hutton, and E. Fuchs Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis Mol Cell Biol 12 10 1992 4643 4653
48. M. Sibilia, A. Fleischmann, A. Behrens, L. Stingl, J. Carroll, and F.M. Watt The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development Cell 102 2 2000 211 220
49. L.A. Hansen, R.L. Woodson, S. Holbus, K. Strain, Y.C. Lo, and S.H. Yuspa The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors Cancer Res 60 13 2000 3328 3332
50. J. DiGiovanni, D.K. Bol, E. Wilker, L. Beltran, S. Carbajal, and S. Moats Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion Cancer Res 60 6 2000 1561 1570
51. J.M. Angel, and J. DiGiovanni Genetics of skin tumor promotion Prog Exp Tumor Res 35 143-157 1999 143 157
52. S.E. Rutberg, T.L. Adams, A. Glick, M.T. Bonovich, C. Vinson, and S.H. Yuspa Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes Cancer Res 60 22 2000 6332 6338
53. E. Saez, S.E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, and S.H. Yuspa c-fos is required for malignant progression of skin tumors Cell 82 5 1995 721 732
54. X.J. Wang, K.M. Liefer, D.A. Greenhalgh, and D.R. Roop 12-O-Tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation Mol Carcinog 26 4 1999 305 311
55. M.R. Young, J.J. Li, M. Rincon, R.A. Flavell, B.K. Sathyanarayana, and R. Hunziker Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion Proc Natl Acad Sci USA 96 17 1999 9827 9832
56. S. Zhu, K. Yoon, E. Sterneck, P.F. Johnson, and R.C. Smart CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signalling Proc Natl Acad Sci USA 99 1 2002 207 212
57. K.S. Chan, S. Sano, K. Kiguchi, J. Anders, N. Komazawa, and J. Takeda Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis J Clin Invest 114 5 2004 720 728
58. S. Wach, P. Schirmacher, M. Protschka, and M. Blessing Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members Oncogene 20 53 2001 7761 7769
59. B.H. Weeks, W. He, K.L. Olson, and X.J. Wang Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis Cancer Res 61 20 2001 7435 7443
60. A.G. Li, S.L. Lu, M.X. Zhang, C. Deng, and X.J. Wang Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis Cancer Res 64 21 2004 7836 7845
61. J. DiGiovanni Multistage carcinogenesis in mouse skin Pharmacol Ther 54 1 1992 63 128
62. P.J. Reddig, N.E. Dreckschmidt, H. Ahrens, R. Simsiman, C.P. Tseng, and J. Zou Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate Cancer Res 59 22 1999 5710 5718
63. P.J. Reddig, N.E. Dreckschmidt, J. Zou, S.E. Bourguignon, T.D. Oberley, and A.K. Verma Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion Cancer Res 60 3 2000 595 602
64. K. Chida, T. Hara, T. Hirai, C. Konishi, K. Nakamura, and K. Nakao Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis Cancer Res 63 10 2003 2404 2408
65. A. Alt, M. Ohba, L. Li, M. Gartsbein, A. Belanger, and M.F. Denning Protein kinase Cdelta-mediated phosphorylation of alpha6beta4 is associated with reduced integrin localization to the hemidesmosome and decreased keratinocyte attachment Cancer Res 61 11 2001 4591 4598
66. E. Joseloff, C. Cataisson, H. Aamodt, H. Ocheni, P. Blumberg, and A.J. Kraker Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes J Biol Chem 277 14 2002 12318 12323
67. T.G. O'Brien, L.C. Megosh, G. Gilliard, and A.P. Soler Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin Cancer Res 57 13 1997 2630 2637
68. Y. Guo, J.L. Cleveland, and T.G. O'Brien Haploinsufficiency for odc modifies mouse skin tumor susceptibility Cancer Res 65 4 2005 1146 1149
69. H.F. Tiano, C.D. Loftin, J. Akunda, C.A. Lee, J. Spalding, and A. Sessoms Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Res 62 12 2002 3395 3401
70. A.P. Pentland, G. Scott, J. VanBuskirk, C. Tanck, G. LaRossa, and S. Brouxhon Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors Cancer Res 64 16 2004 5587 5591
71. G.W. McLean, N.H. Komiyama, B. Serrels, H. Asano, L. Reynolds, and F. Conti Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression Genes Dev 18 24 2004 2998 3003
72. E. Gonzalez-Suarez, E. Samper, A. Ramirez, J.M. Flores, J. Martin-Caballero, and J.L. Jorcano Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes EMBO J 20 11 2001 2619 2630
73. E. Gonzalez-Suarez, E. Samper, J.M. Flores, and M.A. Blasco Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis Nat Genet 26 1 2000 114 117
74. D. Martin-Oliva, F. O'Valle, J.A. Munoz-Gamez, M.T. Valenzuela, M.I. Nunez, and M. Aguilar Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia Oncogene 23 31 2004 5275 5283
75. Y. Xiaochun, K. Minter-Dykhouse, L. Malureanu, W.-M. Zhao, D. Zhang, and C.J. Merkle Chfr is required for tumor suppression and Aurora A regulation Nature Genet 37 4 2005 401 406
76. A.M. Pierce, R. Schneider-Broussard, I.B. Gimenez-Conti, J.L. Russell, C.J. Conti, and D.G. Johnson E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model Mol Cell Biol 19 9 1999 6408 6414
77. Y.P. Lu, Y.R. Lou, P. Yen, H.L. Newmark, O.I. Mirochnitchenko, and M. Inouye Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase Cancer Res 57 8 1997 1468 1474
78. D.J. Long, R.L. Waikel, X.J. Wang, D.R. Roop, and A.K. Jaiswal NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin J Natl Cancer Inst 93 15 2001 1166 1170
79. K. Iskander, M. Paquet, C. Brayton, and A.K. Jaiswal Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a) anthracene and benzo(a)pyrene-induced skin carcinogenesis Cancer Res 64 17 2004 5925 5928
80. D. Mustacich, A. Wagner, R. Williams, W. Bair, L. Barbercheck, and S.P. Stratton Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse Carcinogenesis 25 10 2004 1983 1989
81. Y. Zhao, Y. Xue, T.D. Oberley, K.K. Kiningham, S.M. Lin, and H.C. Yen Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model Cancer Res 61 16 2001 6082 6088
82. A. Mann, K. Breuhahn, P. Schirmacher, A. Wilhelmi, C. Beyer, and A. Rosenau Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms Cancer Res 61 5 2001 2311 2319
83. G.M. Zinser, J.P. Sundberg, and J. Welsh Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis Carcinogenesis 23 12 2002 2103 2109
84. J. Reichelt, G. Furstenberger, and T.M. Magin Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice J Invest Dermatol 123 5 2004 973 981
85. K. Yamakage, Y. Omori, M.L. Zaidan-Dagli, M.P. Cros, and H. Yamasaki Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted J Invest Dermatol 114 2 2000 289 294
86. F. Capozza, T.M. Williams, W. Schubert, S. McClain, B. Bouzahzah, and F. Sotgia Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation Am J Pathol 162 6 2003 2029 2039
87. P.F. Lambert, H. Pan, H.C. Pitot, A. Liem, M. Jackson, and A.E. Griep Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice Proc Natl Acad Sci USA 90 12 1993 5583 5587
88. J.A. Curran, F.S. Laverty, D. Campbell, J. Macdiarmid, and J.B. Wilson Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis Cancer Res 61 18 2001 6730 6738
89. T. Hawighorst, P. Velasco, M. Streit, Y.K. Hong, T.R. Kyriakides, and L.F. Brown Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism EMBO J 20 11 2001 2631 2640
90. H.M. Zhou, I. Bolon, A. Nichols, A. Wohlwend, and J.D. Vassalli Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice Cancer Res 61 3 2001 970 976
91. M. Suganuma, S. Okabe, M.W. Marino, A. Sakai, E. Sueoka, and H. Fujiki Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice Cancer Res 59 18 1999 4516 4518
92. R.J. Moore, D.M. Owens, G. Stamp, C. Arnott, F. Burke, and N. East Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis Nat Med 5 7 1999 828 831
93. M. Girardi, E. Glusac, R.B. Filler, S.J. Roberts, I. Propperova, and J. Lewis The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer J Exp Med 198 5 2003 747 755
94. J.E. Murphy, R.E. Morales, J. Scott, and T.S. Kupper IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis J Immunol 170 11 2003 5697 5703
95. H. Rossiter, S. Beissert, C. Mayer, M.P. Schon, B.G. Wienrich, and E. Tschachler Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis Cancer Res 61 9 2001 3619 3626
96. J. Rodriguez-Villanueva, D. Greenhalgh, X.J. Wang, D. Bundman, S. Cho, and M. Delehedde Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation Oncogene 16 7 1998 853 863 19
97. J.C. Pena, C.M. Rudin, and C.B. Thompson A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas Cancer Res 58 10 1998 2111 2116
98. S.H. Cho, M. Delehedde, J. Rodriguez-Villanueva, S. Brisbay, and T.J. McDonnell Bax gene disruption alters the epidermal response to ultraviolet irradiation and in vivo induced skin carcinogenesis Int J Mol Med 7 3 2001 235 241
99. S.M. Allen, S.R. Florell, A.N. Hanks, A. Alexander, M.J. Diedrich, and D.C. Altieri Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression Cancer Res 63 3 2003 567 572
100. A. Ziegler, A.S. Jonason, D.J. Leffell, J.A. Simon, H.W. Sharma, and J. Kimmelman Sunburn and p53 in the onset of skin cancer Nature 372 1994 773 776
101. A.I. Robles, M.L. Rodriguez-Puebla, A.B. Glick, C. Trempus, L. Hansen, and P. Sicinski Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo Genes Dev 12 16 1998 2469 2474
102. M.L. Rodriguez-Puebla, M. LaCava, and C.J. Conti Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development Cell Growth Differ 10 7 1999 467 472
103. S.G. Rane, S.C. Cosenza, R.V. Mettus, and E.P. Reddy Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence Mol Cell Biol 22 2 2002 644 656
104. M.L. Rodriguez-Puebla, P.L. Miliani de Marval, M. LaCava, D.S. Moons, H. Kiyokawa, and C.J. Conti Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation Am J Pathol 161 2 2002 405 411
105. W.C. Weinberg, N.E. Montano, and C. Deng Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis Oncogene 15 6 1997 685 690
106. M. Nicolas, A. Wolfer, K. Raj, J.A. Kummer, P. Mill, and M. van Noort Notch1 functions as a tumor suppressor in mouse skin Nat Genet 23 2003 416 421
107. M. Tarutani, T. Cai, M. Dajee, and P.A. Khavari Inducible activation of Ras and Raf in adult epidermis Cancer Res 63 2 2003 319 323
108. C.J. Kemp, L.A. Donehower, A. Bradley, and A. Balmain Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors Cell 74 1993 813 822
109. S.W. Lowe, and C.J. Sherr Tumor suppression by Ink4a-Arf: progress and puzzles Curr Opin Genet Dev 13 1 2003 77 83
110. K.S. Kelly-Spratt, K.E. Gurley, Y. Yasui, and C.J. Kemp p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways PLoS Biol 2 8 2004 E242
111. A. Buchmann, B. Ruggeri, A.J.P Klein-Szanto, and A. Balmain Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7 Cancer Res 51 1991 4097 4101
112. A. Glick, N. Popescu, V. Alexander, H. Ueno, E. Bottinger, and S.H. Yuspa Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes Proc Natl Acad Sci USA 96 26 1999 14949 14954
113. M. Oft, R.J. Akhurst, and A. Balmain Metastasis is driven by sequential elevation of H-ras and Smad2 levels Nat Cell Biol 4 7 2002 487 494
114. C.P. Webb, L. van Aelst, M.H. Wigler, and G.F. Woude Signaling pathways in Ras-mediated tumorigenicity and metastasis Proc Natl Acad Sci USA 95 15 1998 8773 8778
115. S.L. Rutherford From genotype to phenotype: buffering mechanisms and the storage of genetic information Bioessays 22 12 2000 1095 1105